CD55 anticorps (AA 51-79)

N° du produit ABIN3030560

L’anticorps Lapin Polyclonal anti-CD55 a été validé pour WB, FACS, IHC, IF et ELISA. Il convient pour détecter CD55 dans des échantillons de Humain.

Aperçu rapide pour CD55 anticorps (AA 51-79) (ABIN3030560)

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CD55 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA

Détail du produit anti-CD55 anticorps

Épitope: AA 51-79

Purification: Antigen affinity purified

Immunogène: A portion of amino acids 51-79 from the human protein was used as the immunogen for this CD55 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: Titration of the CD55 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,Immunofluorescence: 1:10-1:50,IHC (Paraffin): 1:10-1:50,Flow Cytometry: 1:10-1:50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the CD55 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Détails sur CD55

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Autre désignation: CD55

Sujet: This gene encodes a protein involved in the regulation of the complement cascade. The encoded glycoprotein is also known as the decay-accelerating factor (DAF), binding of DAF to complement proteins accelerates their decay, disrupting the cascade and preventing damage to host cells. Antigens present on the DAF glycoprotein constitute the Cromer blood group system (CROM). Two alternatively spliced transcripts encoding different proteins have been identified. The predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma component proteins but an alternatively spliced transcript produces a soluble protein present at much lower levels. Additional, alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq].

UniProt: P08174

Pathways: Système du Complément, Regulation of Leukocyte Mediated Immunity